Effect of glucose levels in increased neutrophil extracellular trap formation (NETS) in type 2 diabetes patients at diagnosis and after 6 and 12 months of metabolic control

被引：0
|
作者：
Schattner, M. A. [1 ]
Carestia, A. [1 ,2 ]
Frechtel, G. [2 ]
Cerrone, G. [2 ]
Gonzalez, C. [3 ]
Linari, M. A. [4 ]
Casais, P. [1 ]
机构：
[1] Natl Acad Med, CONICET, Inst Expt Med, Expt Thrombosis, Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Sch Pharm & Biochem, Dept Microbiol, Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Sch Med, Dept Pharmacol, Buenos Aires, DF, Argentina
[4] NORMED UOM, Nutr & Endocrinol, Buenos Aires, DF, Argentina
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO323-MON
引用
收藏
页码：379 / 379
页数：1
相关论文
共 37 条
  • [1] Circulating Neutrophil Extracellular Trap Levels in Well-Controlled Type 2 Diabetes and Pathway Involved in Their Formation Induced by High-Dose Glucose
    Miyoshi, Arina
    Yamada, Mai
    Shida, Haruki
    Nakazawa, Daigo
    Kusunoki, Yoshihiro
    Nakamura, Akinobu
    Miyoshi, Hideaki
    Tomaru, Utano
    Atsumi, Tatsuya
    Ishizu, Akihiro
    PATHOBIOLOGY, 2016, 83 (05) : 243 - 251
  • [2] Increased formation of neutrophil extracellular traps is associated with gut leakage in patients with type 1 but not type 2 diabetes
    You, Qi
    He, Dong Mei
    Shu, Guo Fang
    Cao, Bo
    Xia, Yong Quan
    Xing, Yun
    Ni, Min
    Chen, Ji Fang
    Shi, Shu Li
    Gu, Harvest F.
    Liu, Yu
    Wu, Jie
    JOURNAL OF DIABETES, 2019, 11 (08) : 665 - 673
  • [3] Pramlintide therapy in addition to insulin in type 2 diabetes: Effect on metabolic control after 6 months.
    Gottlieb, A
    Fineman, M
    Bahner, A
    Parker, J
    Waite, G
    Kolterman, O
    DIABETOLOGIA, 1999, 42 : A232 - A232
  • [4] Effect of glucose control on lipid levels in patients with type 2 diabetes
    Parhofer, KG
    Laubach, E
    Geiss, HC
    Otto, C
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (18) : 958 - 962
  • [5] Pramlintide therapy in addition to insulin in type 1 diabetes: Effect on metabolic control after 6 months.
    Fineman, M
    Gottlieb, A
    Bahner, A
    Parker, J
    Waite, G
    Kolterman, O
    DIABETOLOGIA, 1999, 42 : A232 - A232
  • [6] THE EVOLUTION OF RESTING METABOLIC RATE AND BODY COMPOSITION AFTER 6 AND 12 MONTHS OF LIFESTYLE CHANGES IN OBESE TYPE 2 DIABETES PATIENTS
    Stefan, Diana Simona
    Lixandru, Daniela
    Bajko, Daiana
    Petcu, Laura
    Picu, Ariana
    Pantea, Ileana
    Smeu, Bogdan
    Copaescu, Catalin
    Ionescu-Tirgoviste, Constantin
    Guja, Cristian
    INTERDIAB 2017: DIABETES MELLITUS IN INTERNAL MEDICINE, 2017, : 323 - 331
  • [7] The effect of self-monitoring of blood glucose on metabolic control in type 2 diabetes patients
    Czupryniak, L.
    Szymanska-Garbacz, E.
    Saryusz-Wolska, M.
    Pawlowski, M.
    Sojczynska, J.
    Wojcik-Odyniec, J.
    Jakubczyk, E.
    Szymborska-Kajanek, A.
    Wrobel, M.
    Ruprecht, Z.
    Majcher-Witczak, G.
    Trojak, A.
    Malecki, M. T.
    Loba, J.
    Strojek, K.
    DIABETOLOGIA, 2011, 54 : S32 - S33
  • [8] THE FIBRINOLYTIC RESPONSE TO EXERCISE AT DIAGNOSIS AND AFTER 12 MONTHS IN PATIENTS WITH TYPE-2 DIABETES-MELLITUS
    GOUGH, SCL
    MCCORMACK, L
    RICE, PJS
    GRANT, PJ
    FIBRINOLYSIS, 1994, 8 (06) : 372 - 377
  • [9] Circulating levels of eight miRNAs had a disease-related effect on diabetes duration 1, 3, 6, 12 and 60 months after diagnosis in children with type 1 diabetes
    Samandari, N.
    Mirza, A. H.
    Nielsen, L. B.
    Kaur, S.
    Hougaard, P.
    Porksen, S.
    Andersen, M. -L. M.
    Fredheim, S.
    Johannesen, J.
    Svensson, J.
    Hansen, L.
    Mortensen, H. B.
    Pociot, F.
    DIABETOLOGIA, 2016, 59 : S175 - S176
  • [10] Improvement of Metabolic Control after Three Months of Continuous Glucose Monitoring in Patients With Diabetes Mellitus Type 1 Treated With Insulin Pump Therapy
    Didangelos, Triantafillos
    Iliadis, Fotios
    Zantidis, Anestis
    Margaritidis, Charalampos
    Hatzitolios, Apostolos
    DIABETES, 2013, 62 : A643 - A643
1234